Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Younger

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cancer Treatment Reviews|February 1, 2008
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxelMinetta C Liu, George D Demetri, Donald A Berry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot studyHarold J Burstein, Lyndsay N Harris, Rebecca Gelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancerNancy U Lin, Lisa A Carey, Minetta C Liu, et al.
Breast Cancer Research and Treatment|November 8, 2013
A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastasesNancy U Lin, Rachel A Freedman, Naren Ramakrishna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2020
Identification of Somatically Acquired <i>BRCA1/2</i> Mutations by cfDNA Analysis in Patients with Metastatic Breast CancerNeelima Vidula, Taronish Dubash, Michael S Lawrence, et al.
Cancer Cell|June 15, 2004
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifenXiao-Jun Ma, Zuncai Wang, Paula D Ryan, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancer Treatment Reviews|February 1, 2008
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxelMinetta C Liu, George D Demetri, Donald A Berry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot studyHarold J Burstein, Lyndsay N Harris, Rebecca Gelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancerNancy U Lin, Lisa A Carey, Minetta C Liu, et al.
Breast Cancer Research and Treatment|November 8, 2013
A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastasesNancy U Lin, Rachel A Freedman, Naren Ramakrishna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2020
Identification of Somatically Acquired <i>BRCA1/2</i> Mutations by cfDNA Analysis in Patients with Metastatic Breast CancerNeelima Vidula, Taronish Dubash, Michael S Lawrence, et al.
Cancer Cell|June 15, 2004
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifenXiao-Jun Ma, Zuncai Wang, Paula D Ryan, et al.
Pageof 3